Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial - Ashina - 2021 - European Journal of Neurology - Wiley Online Library
Novartis announces positive results from a Phase IV study showing superior tolerability and efficacy of Aimovig® (erenumab) compared with topiramate in migraine prevention | Novartis
Erenumab for the Prevention of Migraine, Including the Rationale, Findings and Clinical Implications of the LIBERTY Study - touchNEUROLOGY
A Controlled Trial of Erenumab for Episodic Migraine | NEJM
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine - David W Dodick, Messoud Ashina, Jan Lewis Brandes, David Kudrow, Michel Lanteri-Minet, Vera Osipova, Kerry Palmer, Hernan Picard, Daniel D
Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study - Shuu-Jiun Wang, Artemio A Roxas, Bibiana Saravia,
![PDF] ARISE: A Phase 3 randomized trial of erenumab for episodic migraine | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/57b8c7a7cd9246b7072730224457f3a70d5b4e82/5-Table2-1.png "PDF] ARISE: A Phase 3 randomized trial of erenumab for episodic migraine | Semantic Scholar")
PDF] ARISE: A Phase 3 randomized trial of erenumab for episodic migraine | Semantic Scholar
Early onset of efficacy with erenumab in patients with episodic and chronic migraine | The Journal of Headache and Pain | Full Text
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study - The Lancet
Novartis data show Aimovig® cuts acute migraine medication days by half in patients who failed prior preventive therapies | Novartis
A Controlled Trial of Erenumab for Episodic Migraine ... | GrepMed
Erenumab: First-in-Class Approved for Migraine Prevention
Optimal treatment strategy of fremanezumab in migraine prevention: a systematic review with network meta-analysis of randomized clinical trials | Scientific Reports
JCM | Free Full-Text | Reducing the Burden of Migraine: Safety and Efficacy of CGRP Pathway-Targeted Preventive Treatments
Methodologies and outcomes of clinical trials of erenumab in episodic... | Download Scientific Diagram
A Controlled Trial of Erenumab for Episodic Migraine | NEJM
Frontiers | Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus
Aimovig® (erenumab-aooe) for the Preventive Treatment of Migraine in Adults
Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial - The Lancet
Post hoc analysis of clinical trial data and pharmacokinetic data to assess wearing‐off of erenumab within monthly treatment cycle - Dodick - Headache: The Journal of Head and Face Pain - Wiley
Long-term Efficacy and Safety of Erenumab | Neurology
Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials | The Journal of Headache and Pain | Full Text
One-year sustained efficacy of erenumab in episodic migraine | Neurology
